Yuzuru Takemura
Department of Laboratory Medicine
National Defense Medical College
Tokorozawa
Saitama 359-8513
Japan
Name/email consistency: high
- Economic consequence of immediate testing for C-reactive protein and leukocyte count in new outpatients with acute infection. Takemura, Y., Ishida, H., Saitoh, H., Kure, H., Kakoi, H., Ebisawa, K., Kure, M. Clin. Chim. Acta (2005)
- Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count. Takemura, Y., Ebisawa, K., Kakoi, H., Saitoh, H., Kure, H., Ishida, H., Kure, M. J. Clin. Pathol. (2005)
- Immediate availability of C-reactive protein and leukocyte count data influenced physicians' decisions to prescribe antimicrobial drugs for new outpatients with acute infections. Takemura, Y., Kakoi, H., Ishida, H., Kure, H., Tatsuguchi-Harada, Y., Sugawara, M., Inoue, Y., Ebisawa, K., Kure, M. Clin. Chem. (2004)
- Utilization of common inflammatory markers in new, symptomatic, primary care outpatients based on their cost-effectiveness. Takemura, Y., Ishida, H., Inoue, Y. Clin. Chem. Lab. Med. (2003)
- Yield and cost of individual common diagnostic tests in new primary care outpatients in Japan. Takemura, Y., Ishida, H., Inoue, Y., Beck, J.R. Clin. Chem. (2002)
- Laboratory testing under managed care dominance in the USA. Takemura, Y., Beck, J.R. J. Clin. Pathol. (2001)
- Antifolate resistance and its circumvention by new analogues. Takemura, Y., Kobayashi, H., Miyachi, H. Hum. Cell (2001)
- Opportunistic discovery of occult disease by use of test panels in new, symptomatic primary care outpatients: yield and cost of case finding. Takemura, Y., Ishida, H., Inoue, Y., Kobayashi, H., Beck, J.R. Clin. Chem. (2000)
